The C15orf61 Knockout HeLa Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the C15orf61 gene in HeLa cells. This product provides a mixed pool of edited cells, each harboring genetic modifications that abolish functional expression of the C15orf61 long non-coding RNA (lncRNA), enabling loss-of-function analysis without clonal bias.
HeLa cells are an immortalized human epithelial cell line originating from cervical adenocarcinoma, widely employed as a model for studying cancer cell biology. Their characterized signaling networks and robust proliferation make them particularly suitable for examining genes involved in tumorigenic processes such as uncontrolled growth and migration, directly relevant to the study of lncRNA regulatory roles in cervical cancer.
C15orf61 is a lncRNA implicated in gene regulation through interactions with miRNAs and RNA-binding proteins. It likely functions within ceRNA networks, sequestering miRNAs to modulate downstream protein-coding gene expression. Key partners include miRNAs, transcription factors, and epigenetic modifiers. CRISPR/Cas9-mediated disruption of C15orf61 is expected to perturb these interactions, derepressing miRNA targets and altering transcriptional programs that drive cell proliferation and migration. Consequently, the knockout model facilitates investigation into how lncRNA-mediated miRNA sponging influences oncogenic phenotypes.
Applying this knockout model in HeLa cells enables direct exploration of C15orf61??s role in cervical adenocarcinoma biology. The polyclonal format captures a range of editing outcomes, minimizing clonal artifacts and strengthening phenotype?Cgenotype correlations. Because HeLa cells retain intrinsic cancer-driving pathways, the model offers a relevant context to link C15orf61 function to aberrant proliferation and motility, shedding light on lncRNA-dependent mechanisms in tumor progression.
Researchers can leverage these cells for functional genomics studies, employing assays such as RNA-seq and RT-qPCR to map transcriptomic changes, and proliferation, migration, and invasion assays to assess phenotypic impacts. miRNA quantification provides additional insight into altered regulatory networks. The C15orf61 Knockout HeLa Polyclonal Cells thus serve as a practical resource for dissecting lncRNA biology in cancer. For technical support or further information, contact Ascent Research.
